Affiliations 

  • 1 Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore
  • 2 Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
  • 3 Division of Gastroenterology and Hepatology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 4 Department of Medicine, Box Hill Hospital, Monash University, Box Hill, Victoria, Australia
  • 5 Department of Gastroenterology, Changi General Hospital, Singapore
  • 6 Department of Gastroenterology, Tan Tock Seng Hospital, Singapore
  • 7 Department of Internal Medicine, National Taiwan University, Taipei, Taiwan
  • 8 Department of Medicine, University of Hong Kong, Hong Kong
  • 9 Department of Colorectal Surgery, Singapore General Hospital, Singapore
  • 10 Department of Medicine, University of Otago, Christchurch, New Zealand
  • 11 Division of Gastroenterology, Department of Internal Medicine, West China Hospital, Sichuan University, Chengdu, China
  • 12 Department of Medicine, University of Santo Tomas, Manila, Philippines
  • 13 Department of Medicine, Division of Gastroenterology, Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 14 Department of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
  • 15 Division of Gastroenterology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
  • 16 Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  • 17 Hospital Sultanah Bahiyah, Alor Setar, Malaysia
  • 18 Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong
  • 19 Kitasato University, Tokyo, Japan
  • 20 Department of Paediatrics, University of Malaya, Kuala Lumpur, Malaysia
  • 21 Concord Hospital, Gastroenterology and Liver Services, Sydney, New South Wales, Australia
J Gastroenterol Hepatol, 2016 Jan;31(1):45-55.
PMID: 25819140 DOI: 10.1111/jgh.12956

Abstract

Inflammatory bowel disease (IBD) was previously thought to be rare in Asia, but emerging data indicate rising incidence and prevalence of IBD in the region. The Asia Pacific Working Group on Inflammatory Bowel Disease was established in Cebu, Philippines, at the Asia Pacific Digestive Week conference in 2006 under the auspices of the Asian Pacific Association of Gastroenterology with the goal of developing best management practices, coordinating research, and raising awareness of IBD in the region. The consensus group previously published recommendations for the diagnosis and management of ulcerative colitis with specific relevance to the Asia-Pacific region. The present consensus statements were developed following a similar process to address the epidemiology, diagnosis, and management of Crohn's disease. The goals of these statements are to pool the pertinent literature specifically highlighting relevant data and conditions in the Asia-Pacific region relating to the economy, health systems, background infectious diseases, differential diagnoses, and treatment availability. It does not intend to be all comprehensive and future revisions are likely to be required in this ever-changing field.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications